INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 438m ago
HOUSE PTR38m ago
SEC 13F38m ago
ROBINHOOD CHAIN37m ago
Corporate insider
LW

Lloyd George W.

EVP, Investments & CLOCIK 0001814899

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 11
Max Insider Score31
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$3.06M
79.3K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Royalty Pharma plcEVP, Investments & CLO · Nov 7, 2025
24
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL
$1.18M
30.7K sh
Dec 18, 2025
Dec 19, 2025
traded Dec 18, 2025
+1d
SEC FORM 4

Evidence

29
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$4.38M
110.0K sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC FORM 4

Evidence

31
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.83M
47.8K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

21
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$181K
4,628 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

31
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.81M
47.4K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$179K
4,599 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

28
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$977K
25.5K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$96K
2,470 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$106K
2,770 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

22
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$8,978
230 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

13
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Grant or award
A—
6,168 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence